Skip to content
naulon
Not checkedNot checked for notices yet.

Editorial

Grace L. Guo, Huiping Zhou

Acta Pharmaceutica Sinica B · 2015

doi:10.1016/j.apsb.2015.03.002 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Bile acids have been traditionally viewed as detergent molecules involved in the solubilization and absorption of lipids and lipidsoluble vitamins from the intestines.However, as a result of intensive research over the past two decades, bile acids are now viewed as endocrine signaling molecules that activate specific nuclear receptors and G-protein coupled receptors regulating nutrient metabolism in the liver and intestines.The year 2015 marks the 20-year anniversary of the cloning and discovery of farnesoid X receptor (NR4H1; FXR).FXR is a main bile acid nuclear receptor and plays an essential role in the regulation of bile acids, lipids, glucose and drug metabolism, as well as inhibiting inflammation and suppressing carcinogenesis in the liver and intestine.Bile acids also activate pregnane X receptor, constitutive androstane receptor, vitamin D receptor, G protein-coupled bile acid receptor (TGR5), and sphingosine-1-phosphate receptor 2 (S1PR2) to regulate growth and functions of hepatocytes, cholangiocytes and enterocytes.Moreover, bile acids also induce, via FXR, critical regulators of metabolism, inflammation and carcinogenesis in the liver and intestine, including small heterodimer partner (SHP) and fibroblast growth factor 15/19 (FGF15/19).

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.